Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision history now includes a new entry for v3.5.2. The previous v3.5.0 entry has been removed.
    Difference
    0.1%
    Check dated 2026-04-15T22:07:37.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-25T06:54:38.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision v3.4.3 appears in the history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-10T17:52:09.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The Study Record History now includes a new revision entry v3.4.2, replacing the previous v3.4.1 revision. This appears to be a minor update to the revision metadata rather than a change to study data.
    Difference
    0.1%
    Check dated 2026-02-17T03:20:41.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry added: v3.4.1 to the history. The prior Notice about government funding and the earlier revision v3.4.0 are shown as deletions in the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-09T22:26:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, warning that information may not be up to date and that transactions may not be processed, with references to cc.nih.gov and opm.gov for status updates.
    Difference
    0.8%
    Check dated 2026-02-02T20:38:49.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.